-transparent.png){kind=logo}
Psychiatric outpatients were assessed for dyskinetic movements using the abnormal involuntary movement scale (AIMS). The prevalence of tardive dyskinesia in an Australian sample of 66 patients was 44% which is similar to reported prevalence in other countries. Although the prevalence was significantly higher in patients over 45 years of age and with more than a 5 year history of neuroleptic medication, there were no significant correlations between presence of dyskinesias and age, sex or duration of neuroleptic treatment. Organic factors such as neurological disorders, ECT or alcoholism were not related to dyskinetic movements, nor was the use of anticholinergic or tricyclic antidepressant medication. The AIMS is a reliable rating scale for dyskinetic movements and could be used more widely as a screening instrument for early detection of tardive dyskinesia.
J M Rey, and
G E Hunt, and
G F Johnson
August 1979,
Psychopharmacology,
J M Rey, and
G E Hunt, and
G F Johnson
January 1988,
Psychopharmacology bulletin,
J M Rey, and
G E Hunt, and
G F Johnson
December 1977,
The American journal of psychiatry,
J M Rey, and
G E Hunt, and
G F Johnson
January 1983,
Psychopharmacology bulletin,
J M Rey, and
G E Hunt, and
G F Johnson
January 1982,
Psychopharmacology bulletin,
J M Rey, and
G E Hunt, and
G F Johnson
June 1979,
Psychopharmacology,
J M Rey, and
G E Hunt, and
G F Johnson
January 1984,
Psychopharmacology bulletin,
J M Rey, and
G E Hunt, and
G F Johnson
April 1977,
Acta psychiatrica Scandinavica,
J M Rey, and
G E Hunt, and
G F Johnson
September 1988,
L'Encephale,
J M Rey, and
G E Hunt, and
G F Johnson
January 1985,
Annals of the Academy of Medicine, Singapore,
